* Says Allergan aims to limit annual price increases of
branded therapeutic drugs to low to mid single digit percentage
range, slightly above current annual rate of inflation
* Says Allergan's planned price increase limits would be
similar to company's price increases seen in 2016, and should
follow in 2017, beyond
* Says Hillary Clinton's plan for oversight panels to monitor,
punish drugmakers that impose unreasonable price increases on
life-saving drugs impractical in free market system
Read more
No comments:
Post a Comment